Local Effects of Two Intravenous Formulations of Pulmonary Vasodilators on Airway Epithelium | Respiratory Care
Inhaled Treprostinil effective in Pulmonary Hypertension Due to ILD: NEJM study
Ultrasonic versus jet nebulization of iloprost in severe pulmonary hypertension | European Respiratory Society
Ultrasonic versus jet nebulization of iloprost in severe pulmonary hypertension | European Respiratory Society
Administering Treprostinil to an Intubated Patient Kristen Merriman, MS, RRT-ACCS, RRT-NPS, AE-C, RCP Director of Cardiopulmonary & Neurodiagnostic Services. - ppt download
Tyvaso Inhalation Solution for Pulmonary Hypertension
Modification Tadalafil and Macitentan tablets to aerosol
FDA-approved Treatments for Pulmonary Hypertension | Vera Moulton Wall Center for Pulmonary Vascular Disease | Stanford Medicine
Inhaled Pulmonary Vasodilators - EMCrit Project
FDA-approved Treatments for Pulmonary Hypertension | Vera Moulton Wall Center for Pulmonary Vascular Disease | Stanford Medicine
TYVASO® (treprostinil) Nebulizer
FDA approves inhaled pulmonary hypertension treatment from United Therapeutics - Drug Delivery Business
Practical considerations in the management of inhaled prostacyclin therapy for pulmonary hypertension associated with interstitial lung disease (WHO group 3) - ScienceDirect
Tyvaso DPITM for PAH Receives Priority Review Acceptance From FDA
Inhaled Prostacyclin | TYVASO® (treprostinil)
TYVASO® (treprostinil) Nebulizer | PH-ILD
Inhaled Pulmonary Vasodilators - EMCrit Project
Pulmonary Hypertension Symptoms, Risk Factors, Diagnosis and Treatment | Narayana Health
Novel Inhaled Treprostinil May Benefit Persons with Pulmonary Hypertension - Physician's Weekly
Pulmonary hypertension inhaled therapies: An updated review - ScienceDirect
Inhaled Iloprost | Idiopathic Pulmonary Arterial Hypertension
Antioxidants | Free Full-Text | Reactive Oxygen and Nitrogen Species in the Development of Pulmonary Hypertension
